Case 2
At Optima Education we believe that medical education can be better. Technology is changing and with it the way that we learn. We believe that ideas, concepts and techniques can, and should, be...
At Optima Education we believe that medical education can be better. Technology is changing and with it the way that we learn. We believe that ideas, concepts and techniques can, and should, be expressed more clearly. We believe that learning is quicker, with more information being retained when it is presented in the correct way.
Speakers
Masahisa Yamane
Speaker
A consultant cardiologist at Sayama Hospital, Saitama, Japan. Features in 4 videos on Wondr... A consultant cardiologist at Sayama Hospital, Saitama, Japan. Features in 4 videos on Wondr Medical. Masahisa Yamane generally speaks on Chronic Total Occlusion (CTO), Live Cases, Bifurcation, Total Occlusion and Bifurcation Interventions, and Coronary Artery Bypass Grafting (CABG).
Simon Walsh
Speaker
Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10... Dr Simon Walsh has been working as a Consultant Cardiologist at the Belfast Trust for over 10 years. It is one of the largest NHS trusts in the UK. The centre performs ~2750 PCI per year, with 650-700 STEMI and calcium modification in ~10% of our PCI cases. Dr Walsh also works internationally as an educator, teaching advanced techniques for complex PCI and CTO PCI. This involves training visiting Cardiologists in Belfast retrograde CTO techniques, antegrade dissection and re-entry CTO techniques and other advanced PCI procedures. He has visited multiple centres in the UK, Ireland, Europe, Australia, Asia and North America to act as a visiting proctor for complex PCI and CTO PCI cases. Dr Walsh’s research interests include PCI, coronary artery disease, defibrillation, acute coronary syndromes and chronic total occlusions. Research responsibilities have included acting as a recruiting investigator for the >25 multicentre studies over the last 17 years. He acted as a primary investigator for numerous international trials including the Evolve, Noble, Leaders Free and Ischemia multicentre studies. He has been the lead UK investigator for the October trial, Syntax 2, Recharge and Ischaemia-CTO. He is also the Chief Investigator for the Consistent CTO, Celtic Bifurcation and Discrete CTO trials.
